This invasiveness was reminiscent of metastatic lung adenocarcinoma fibroblasts, and pathway analysis in fibroblasts from IPF patients suggested this phenotype was mediated by ERBB2 (HER2) signaling (109). The gene discussed is ERBB2; the disease is lung adenocarcinoma.